Light chain deposition disease involving kidney and liver in a patient with IgD myeloma

Abstract Background IgD multiple myeloma (MM) is a rare subtype of MM and light chain deposition disease (LCDD) outside the kidney is also a rare and has scarcely been reported. We report herein the details of the first reported case of LCDD involving the kidney and liver co-occurring with IgD myelo...

Full description

Bibliographic Details
Main Authors: Takafumi Tsushima, Tomo Suzuki, Toshiki Terao, Daisuke Miura, Kentaro Narita, Masami Takeuchi, Akira Shimuzu, Kosei Matsue
Format: Article
Language:English
Published: BMC 2021-01-01
Series:BMC Nephrology
Subjects:
Online Access:https://doi.org/10.1186/s12882-021-02246-9
_version_ 1818563786159685632
author Takafumi Tsushima
Tomo Suzuki
Toshiki Terao
Daisuke Miura
Kentaro Narita
Masami Takeuchi
Akira Shimuzu
Kosei Matsue
author_facet Takafumi Tsushima
Tomo Suzuki
Toshiki Terao
Daisuke Miura
Kentaro Narita
Masami Takeuchi
Akira Shimuzu
Kosei Matsue
author_sort Takafumi Tsushima
collection DOAJ
description Abstract Background IgD multiple myeloma (MM) is a rare subtype of MM and light chain deposition disease (LCDD) outside the kidney is also a rare and has scarcely been reported. We report herein the details of the first reported case of LCDD involving the kidney and liver co-occurring with IgD myeloma. Case presentation A 66-year-old female with IgD MM presented with rapidly progressive acute renal failure, ascites and pleural effusion. Immunofluorescent study of revealed the characteristic linear deposition of Igκ light chain along the glomerular and tubular basement membrane in kidney. Electron microscopy showed the powdery electron-dense deposits along the tubular and glomerular basement membrane consistent with the diagnosis of LCDD. Laser microdissection followed by mass spectrometry identified only Igκ light chain with more than 95% probability confirm the diagnosis of κ-LCDD but not heavy/light chain deposition disease. Liver biopsy with immunofluorescence study revealed the linear deposition of Igκ chain along the perisinusoidal space indicating the hepatic involvement of κ-LCDD. The patient was successfully treated with combination therapy with bortezomib, cyclophosphamide, dexamethasone, and daratumumab. Conclusions This report emphasizes that prompt biopsy of affected organs and initiation of clone directed therapy led to the correct diagnosis and favorable outcome in patient with LCDD who has extrarenal involvement.
first_indexed 2024-12-14T01:20:55Z
format Article
id doaj.art-d2b8e1a46b9b4301a2386008863cc359
institution Directory Open Access Journal
issn 1471-2369
language English
last_indexed 2024-12-14T01:20:55Z
publishDate 2021-01-01
publisher BMC
record_format Article
series BMC Nephrology
spelling doaj.art-d2b8e1a46b9b4301a2386008863cc3592022-12-21T23:22:24ZengBMCBMC Nephrology1471-23692021-01-012211610.1186/s12882-021-02246-9Light chain deposition disease involving kidney and liver in a patient with IgD myelomaTakafumi Tsushima0Tomo Suzuki1Toshiki Terao2Daisuke Miura3Kentaro Narita4Masami Takeuchi5Akira Shimuzu6Kosei Matsue7Division of Hematology/Oncology, Department of Internal Medicine, Kameda Medical CenterDivision of Nephrology, Department of Medicine, Kameda Medical CenterDivision of Hematology/Oncology, Department of Internal Medicine, Kameda Medical CenterDivision of Hematology/Oncology, Department of Internal Medicine, Kameda Medical CenterDivision of Hematology/Oncology, Department of Internal Medicine, Kameda Medical CenterDivision of Hematology/Oncology, Department of Internal Medicine, Kameda Medical CenterDepartment of Analytic Human Pathology, Nippon Medical SchoolDivision of Hematology/Oncology, Department of Internal Medicine, Kameda Medical CenterAbstract Background IgD multiple myeloma (MM) is a rare subtype of MM and light chain deposition disease (LCDD) outside the kidney is also a rare and has scarcely been reported. We report herein the details of the first reported case of LCDD involving the kidney and liver co-occurring with IgD myeloma. Case presentation A 66-year-old female with IgD MM presented with rapidly progressive acute renal failure, ascites and pleural effusion. Immunofluorescent study of revealed the characteristic linear deposition of Igκ light chain along the glomerular and tubular basement membrane in kidney. Electron microscopy showed the powdery electron-dense deposits along the tubular and glomerular basement membrane consistent with the diagnosis of LCDD. Laser microdissection followed by mass spectrometry identified only Igκ light chain with more than 95% probability confirm the diagnosis of κ-LCDD but not heavy/light chain deposition disease. Liver biopsy with immunofluorescence study revealed the linear deposition of Igκ chain along the perisinusoidal space indicating the hepatic involvement of κ-LCDD. The patient was successfully treated with combination therapy with bortezomib, cyclophosphamide, dexamethasone, and daratumumab. Conclusions This report emphasizes that prompt biopsy of affected organs and initiation of clone directed therapy led to the correct diagnosis and favorable outcome in patient with LCDD who has extrarenal involvement.https://doi.org/10.1186/s12882-021-02246-9IgD myelomaLight chain deposition diseaseLiver involvementDaratumumabCyBorD
spellingShingle Takafumi Tsushima
Tomo Suzuki
Toshiki Terao
Daisuke Miura
Kentaro Narita
Masami Takeuchi
Akira Shimuzu
Kosei Matsue
Light chain deposition disease involving kidney and liver in a patient with IgD myeloma
BMC Nephrology
IgD myeloma
Light chain deposition disease
Liver involvement
Daratumumab
CyBorD
title Light chain deposition disease involving kidney and liver in a patient with IgD myeloma
title_full Light chain deposition disease involving kidney and liver in a patient with IgD myeloma
title_fullStr Light chain deposition disease involving kidney and liver in a patient with IgD myeloma
title_full_unstemmed Light chain deposition disease involving kidney and liver in a patient with IgD myeloma
title_short Light chain deposition disease involving kidney and liver in a patient with IgD myeloma
title_sort light chain deposition disease involving kidney and liver in a patient with igd myeloma
topic IgD myeloma
Light chain deposition disease
Liver involvement
Daratumumab
CyBorD
url https://doi.org/10.1186/s12882-021-02246-9
work_keys_str_mv AT takafumitsushima lightchaindepositiondiseaseinvolvingkidneyandliverinapatientwithigdmyeloma
AT tomosuzuki lightchaindepositiondiseaseinvolvingkidneyandliverinapatientwithigdmyeloma
AT toshikiterao lightchaindepositiondiseaseinvolvingkidneyandliverinapatientwithigdmyeloma
AT daisukemiura lightchaindepositiondiseaseinvolvingkidneyandliverinapatientwithigdmyeloma
AT kentaronarita lightchaindepositiondiseaseinvolvingkidneyandliverinapatientwithigdmyeloma
AT masamitakeuchi lightchaindepositiondiseaseinvolvingkidneyandliverinapatientwithigdmyeloma
AT akirashimuzu lightchaindepositiondiseaseinvolvingkidneyandliverinapatientwithigdmyeloma
AT koseimatsue lightchaindepositiondiseaseinvolvingkidneyandliverinapatientwithigdmyeloma